Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Hein

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Melanoma Research|November 1, 1992
Elective lymph node dissection in stage I malignant melanoma: a meta-analysisD W Hein, R L Moy
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbitD W Hein, W W Weber
Clinical Pharmacokinetics|November 1, 1979
Clinical pharmacokinetics of isoniazidW W Weber, D W Hein
Pharmacological Reviews|March 1, 1985
N-acetylation pharmacogeneticsW W Weber, D W Hein
Pharmacogenetics|August 1, 1995
Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred ratsM A Doll, D W Hein
Toxicology and Applied Pharmacology|November 1, 1996
2-Aminofluorene-DNA adduct levels in tumor-target and nontarget organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locusY Feng, W Jiang, D W Hein
Toxicology and Applied Pharmacology|May 1, 1999
Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenylW Jiang, Y Feng, D W Hein
Proceedings of the Western Pharmacology Society|January 1, 1997
DNA adduct levels in rapid and slow acetylator inbred rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridineA J Fretland, Y Feng, D W Hein
Pharmacology|January 1, 1981
An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitroD W Hein, M Hirata, W W Weber
The Journal of Dermatologic Surgery and Oncology|September 1, 1992
A review of sutures and suturing techniquesR L Moy, B Waldman, D W Hein
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Melanoma Research|November 1, 1992
Elective lymph node dissection in stage I malignant melanoma: a meta-analysisD W Hein, R L Moy
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1984
Relationship between N-acetylator phenotype and susceptibility toward hydrazine-induced lethal central nervous system toxicity in the rabbitD W Hein, W W Weber
Clinical Pharmacokinetics|November 1, 1979
Clinical pharmacokinetics of isoniazidW W Weber, D W Hein
Pharmacological Reviews|March 1, 1985
N-acetylation pharmacogeneticsW W Weber, D W Hein
Pharmacogenetics|August 1, 1995
Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred ratsM A Doll, D W Hein
Toxicology and Applied Pharmacology|November 1, 1996
2-Aminofluorene-DNA adduct levels in tumor-target and nontarget organs of rapid and slow acetylator Syrian hamsters congenic at the NAT2 locusY Feng, W Jiang, D W Hein
Toxicology and Applied Pharmacology|May 1, 1999
Higher DNA adduct levels in urinary bladder and prostate of slow acetylator inbred rats administered 3,2'-dimethyl-4-aminobiphenylW Jiang, Y Feng, D W Hein
Proceedings of the Western Pharmacology Society|January 1, 1997
DNA adduct levels in rapid and slow acetylator inbred rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridineA J Fretland, Y Feng, D W Hein
Pharmacology|January 1, 1981
An enzyme marker to ensure reliable determinations of human isoniazid acetylator phenotype in vitroD W Hein, M Hirata, W W Weber
The Journal of Dermatologic Surgery and Oncology|September 1, 1992
A review of sutures and suturing techniquesR L Moy, B Waldman, D W Hein
Pageof 11